Endocrinology, Vol 134, 2088-2094, Copyright © 1994 by Endocrine Society

ARTICLES

Processing and metabolism of peptide-YY: pivotal roles of dipeptidylpeptidase-IV, aminopeptidase-P, and endopeptidase-24.11

MD Medeiros and AJ Turner
Department of Biochemistry and Molecular Biology, University of Leeds, United Kingdom.

The processing of peptide-YY (PYY) by purified membrane peptidases and brush border membrane preparations from human kidney and jejunum has been compared. Dipeptidyl peptidase-IV hydrolyzes PYY at the Pro2-Ile3 bond, producing PYY-(3-36), which is a Y2 receptor-selective ligand. Aminopeptidase-P removes the N-terminal tyrosine from PYY, but the intact peptide is not a substrate for aminopeptidase-N. Endopeptidase- 24.11 (neutral endopeptidase; enkephalinase) metabolizes PYY efficiently, with a major site of hydrolysis at the Asn29-Leu30 bond, an inactivating cleavage. Angiotensin-converting enzyme does not hydrolyze PYY. In renal brush border membranes, hydrolysis of PYY is substantially (> 75%) inhibited by phosphoramidon, suggesting that endopeptidase-24.11 initiates hydrolysis of PYY in this preparation. In jejunal brush border membranes, phosphoramidon has a much smaller effect (15% inhibition), and contributions due to the actions of aminopeptidase-P and dipeptidyl peptidase-IV were evident. Few physiological substrates have yet been identified for aminopeptidase-P and dipeptidyl peptidase-IV; the pancreatic polypeptide fold family, of which PYY is a member, may well represent endogenous substrates for those cell surface ectoenzymes. Dipeptidyl peptidase-IV converts PYY to a metabolite PYY-(3-36), a highly selective agonist for the Y2 receptor type. Thus, the relative levels of the three membrane peptidases at different tissue locations and on different cell types may play a pivotal role in postsecretory processing and metabolism of PYY to receptor-selective agonists or inactive metabolites.

This article has been cited by other articles:

				S.-y. Ueda, T. Yoshikawa, Y. Katsura, T. Usui, and S. Fujimoto Comparable effects of moderate intensity exercise on changes in anorectic gut hormone levels and energy intake to high intensity exercise J. Endocrinol., December 1, 2009; 203(3): 357 - 364. [Abstract] [Full Text] [PDF]

				K. Abid, B. Rochat, P.-G. Lassahn, R. Stocklin, S. Michalet, N. Brakch, J.-F. Aubert, B. Vatansever, P. Tella, I. De Meester, et al. Kinetic Study of Neuropeptide Y (NPY) Proteolysis in Blood and Identification of NPY3-35: A NEW PEPTIDE GENERATED BY PLASMA KALLIKREIN J. Biol. Chem., September 11, 2009; 284(37): 24715 - 24724. [Abstract] [Full Text] [PDF]

				S. Unniappan and T. J. Kieffer Leptin extends the anorectic effects of chronic PYY(3-36) administration in ad libitum-fed rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R51 - R58. [Abstract] [Full Text] [PDF]

				N. Vrang, A. N. Madsen, M. Tang-Christensen, G. Hansen, and P. J. Larsen PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R367 - R375. [Abstract] [Full Text] [PDF]

				T. Talsania, Y. Anini, S. Siu, D. J. Drucker, and P. L. Brubaker Peripheral Exendin-4 and Peptide YY3-36 Synergistically Reduce Food Intake through Different Mechanisms in Mice Endocrinology, September 1, 2005; 146(9): 3748 - 3756. [Abstract] [Full Text] [PDF]

				S. C. Benoit and M. H. Tschop PYY3-36 "monkeys around" with energy balance Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R358 - R359. [Full Text] [PDF]

				C. Zoccali, F. Mallamaci, G. Tripepi, F. A. Benedetto, S. Parlongo, S. Cutrupi, D. Iellamo, G. Bonanno, F. Rapisarda, P. Fatuzzo, et al. Prospective Study of Neuropeptide Y as an Adverse Cardiovascular Risk Factor in End-Stage Renal Disease J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2611 - 2617. [Abstract] [Full Text] [PDF]

				J. E. Park, M. C. Lenter, R. N. Zimmermann, P. Garin-Chesa, L. J. Old, and W. J. Rettig Fibroblast Activation Protein, a Dual Specificity Serine Protease Expressed in Reactive Human Tumor Stromal Fibroblasts J. Biol. Chem., December 17, 1999; 274(51): 36505 - 36512. [Abstract] [Full Text] [PDF]

				A. S. Murphy, K. R. Hoogner, W. A. Peer, and L. Taiz Identification, Purification, and Molecular Cloning of N-1-Naphthylphthalmic Acid-Binding Plasma Membrane-Associated Aminopeptidases from Arabidopsis Plant Physiology, March 1, 2002; 128(3): 935 - 950. [Abstract] [Full Text] [PDF]